X

Vous n'êtes pas connecté

Maroc Maroc - Times of India - Top Stories - 14/Aug 16:27

Phase three clinical trial of India's own dengue vaccine, DengiAll, initiated

India's first phase-three trial for an indigenous tetravalent dengue vaccine, DengiALL, was initiated by Panacea Biotec. Conducted across 19 sites, the trial involves over 10,335 healthy adults. The vaccine aims to address all four dengue serotypes. The Union Health Minister J P Nadda highlighted its significance in combating dengue and enhancing India's vaccine development capabilities.

Articles similaires

BCG vaccine administered to 4.5K adults in ongoing trial to combat TB

hindustantimes.com - 08/Sep 18:35

Pune's health department has vaccinated over 4,524 adults with the BCG vaccine in a study to assess its efficacy against tuberculosis over three...

Launch of National Medical Register Portal

medindia.net - 05/Sep 15:47

Shri Jagat Prakash Nadda inaugurates the National Medical Register (NMR) Portal, a key step in enhancing India's digital healthcare ecosystem with...

INS Arighaat: Key Facts About India’s 2nd Nuclear Ballistic Submarine

popdiaries.com - 30/Aug 12:05

The strategic landscape of naval warfare has undergone a remarkable transformation over the past few decades, with nations increasingly focusing on...

HAL partners with Safhal for ‘Aravalli’ engines to power next-gen choppers

times of india - 30/Aug 09:18

HAL has signed a contract with Safhal Helicopter Engines Pvt Ltd to co-develop the ‘Aravalli’ engine for India’s forthcoming Multi-Role...

Cuba applies Pneumosil10 valente vaccine

acn.cu - 10/Sep 14:34

The Cuban National Health System applies from today the Pneumosil10 valent vaccine to all infants born this year, which prevents 10 of the main...

Cuba applies Pneumosil10 valente vaccine

acn.cu - 10/Sep 14:34

The Cuban National Health System applies from today the Pneumosil10 valent vaccine to all infants born this year, which prevents 10 of the main...

N-Submarines, Power, Purpose, Global Presence: INS Arighat India’s Silent Nuclear Sentinel Deployed – Analysis

eurasiareview.com - 08/Sep 03:54

India recently launched its second nuclear-powered submarine, the INS Arighat, in Visakhapatnam. Defence Minister Rajnath Singh and other...

Sorry! Image not available at this time

GSK's RSV Vaccine Arexvy Gets EU Nod for Adults Aged 50-59 Years

zacks.com - 29/Aug 17:29

The European Commission approves GSK's RSV vaccine, Arexvy, for use in adults aged 50-59 years with increased risk of the disease.

COVID-19 mRNA vaccine linked to myocardial scarring in adolescents and young adults

news.medical.net - 11/Sep 09:53

The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of myocardial injury in young...

Theaterization In India: Streamlining Defence And Enhancing Synergy – Analysis

eurasiareview.com - 09/Sep 23:43

On Thursday (September 5), Defence Minister Rajnath Singh chaired the maiden Joint Commanders’ Conference in Lucknow. He stressed the need for...

Les derniers communiqués

  • Aucun élément